611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors - Concepedia

Concepedia

Publication | Open Access

611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors

DOI Full Paper Access

10

Citations

0

References

2024

Year

J.B.A.G. Haanen, Andréas Mackensen, C. Schultze-Florey, Winfried Alsdorf, E. Wagner-Drouet, Daniel Heudobler, P. Borchmann, Antonia Busse, Stephan Mielke, Sander Bins,

Annals of Oncology

No additional data available for this publication yet. Check back later!